학술논문
Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: The LAPLACE-2 randomized clinical trial
Document Type
Report
Author
Source
JAMA, The Journal of the American Medical Association. May 14, 2014, Vol. 311 Issue 18, p1870, 13 p.
Subject
Language
English
ISSN
0098-7484
Abstract
The article presents a study to evaluate the efficacy and tolerability of evolocumab when used in combination with a moderate- vs high-intensity statin. Percent change from baseline in low-density lipoprotein cholesterol (LDL-C) level at the mean of weeks 10 and 12 and at week 12.